Table 2 Risk of complications from COVID-19 by patient characteristics.

From: Racial disparities in COVID-19 outcomes exist despite comparable Elixhauser comorbidity indices between Blacks, Hispanics, Native Americans, and Whites

Comparison

Hospitalization

Maximum length of stay (days)

Invasive ventilator dependence

Deceased

n (%a)

Median (IQR: Q1–Q3)

n (%a)

n (%a)

Total

27,774 (53.0)

1.6 (0.1–6.5)

6150 (11.7)

4695 (9.0)

Gender

Female

13,307 (50.2)

1.0 (0.1–5.8)

2472 (9.3)

1962 (7.4)

Male

14,406 (55.8)

2.0 (0.1–7.2)

3664 (14.2)

2723 (10.6)

Other

61 (61.6)

2.4 (0.2–6.7)

14 (14.1)

10 (10.1)

Race and ethnicity

Non-Hispanic American Indian or Alaska Native

574 (53.6)

1.9 (0.1–7.8)

236 (22.1)

113 (10.6)

Non-Hispanic Asian or Pacific Islander

876 (60.5)

2.7 (0.2–8.3)

220 (15.2)

150 (10.4)

Non-Hispanic Black or African American

6131 (57.5)

2.1 (0.2–7.5)

1383 (13.0)

1072 (10.0)

Non-Hispanic White

9811 (65.2)

3.0 (0.2–7.8)

2020 (13.4)

1998 (13.3)

Non-Hispanic other

2944 (51.2)

1.2 (0.1–6.9)

822 (14.3)

533 (9.3)

Hispanic or Latino

7438 (40.4)

0.2 (0.1–4.1)

1469 (8.0)

829 (4.5)

Insurance

Private

7067 (39.2)

0.2 (0.1–3.8)

1538 (8.5)

677 (3.8)

Government/miscellaneous

957 (51.6)

1.2 (0.11–6.1)

221 (11.9)

173 (9.3)

Medicaid

4209 (49.0)

0.9 (0.1–5.1)

850 (9.9)

367 (4.3)

Medicare

9442 (80.1)

5.5 (1.9–10.9)

2213 (18.8)

2606 (22.1)

Self-pay

97 (2.0)

0.1 (0.1–0.7)

173 (3.5)

97 (2.0)

Missing

775 (10.7)

3.4 (0.2–8.8)

1155 (15.9)

775 (10.7)

Elixhauser AHRQ-weighted comorbidity group

< 0

3874 (43.2)

0.3 (0.1–4.0)

440 (4.9)

195 (2.2)

0

3041 (18.8)

0.1 (0.1–0.3)

496 (3.1)

252 (1.6)

1–4

1867 (44.2)

0.3 (0.1–4.3)

313 (7.4)

190 (4.5)

≥ 5

18,992 (82.4)

5.4 (2.0–11.2)

4901 (21.3)

4058 (17.6)

  1. aRow percentage.